Basics |
Jaguar Health, Inc.
Jaguar Health Inc is an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value horses.
|
IPO Date: |
May 11, 2015 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$5.58M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.09 | 5.98%
|
Avg Daily Range (30 D): |
$0.52 | 6.79%
|
Avg Daily Range (90 D): |
$0.25 | 5.81%
|
Institutional Daily Volume |
Avg Daily Volume: |
5.65M |
Avg Daily Volume (30 D): |
.17M |
Avg Daily Volume (90 D): |
.26M |
Trade Size |
Avg Trade Size (Sh.): |
840 |
Avg Trade Size (Sh.) (30 D): |
101 |
Avg Trade Size (Sh.) (90 D): |
246 |
Institutional Trades |
Total Inst.Trades: |
69 |
Avg Inst. Trade: |
$1.18M |
Avg Inst. Trade (30 D): |
$.5M |
Avg Inst. Trade (90 D): |
$.5M |
Avg Inst. Trade Volume: |
M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.23M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
K |
|
|
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-147.59
|
$-16.7
|
$-125.8
|
Diluted EPS
|
$-147.59
|
$-16.7
|
$-125.8
|
Revenue
|
$ 11.55M
|
$ 2.21M
|
$ 3.51M
|
Gross Profit
|
$ 9.51M
|
$ 1.7M
|
$ 2.95M
|
Net Income / Loss
|
$ -40.48M
|
$ -10.6M
|
$ -10.23M
|
Operating Income / Loss
|
$ -32.04M
|
$ -9.42M
|
$ -8.16M
|
Cost of Revenue
|
$ 2.04M
|
$ .52M
|
$ .56M
|
Net Cash Flow
|
$ 1.59M
|
$ M
|
$ -5.21M
|
PE Ratio
|
|
|
|
Splits |
Mar 24, 2025:
1:25
|
May 23, 2024:
1:60
|
Jan 23, 2023:
1:75
|
Sep 08, 2021:
1:3
|
Jun 07, 2019:
1:70
|
Jun 01, 2018:
1:15
|
|